Half of hospitalized patients developed complications, even the young and previously healthy
Um estudo britânico de larga escala, publicado no Lancet em julho de 2021, revelou que metade dos mais de 70 mil pacientes hospitalizados com COVID-19 no Reino Unido desenvolveu ao menos uma complicação grave durante a internação — incluindo jovens e adultos previamente saudáveis. Os dados, coletados em quase 300 hospitais antes mesmo das campanhas de vacinação, desafiam a narrativa de que a doença representa risco sério apenas para idosos ou pessoas com comorbidades. O estudo nos lembra que epidemias não negociam com suposições, e que o verdadeiro custo de uma pandemia se mede não apenas em mortes, mas em vidas transformadas pela perda de função e autonomia.
- Metade dos pacientes hospitalizados desenvolveu complicações sérias — renais, respiratórias, cardiovasculares e neurológicas —, derrubando a ideia de que jovens saudáveis estão protegidos da gravidade da doença.
- Entre pacientes de 19 a 29 anos, 27% sofreram ao menos uma complicação; entre os de 30 a 39 anos, o índice chegou a 37%, revelando uma urgência que transcende a faixa etária mais vulnerável.
- 32% dos participantes do estudo morreram, e 27% dos sobreviventes deixaram o hospital menos capazes de cuidar de si mesmos do que antes da infecção — com complicações neurológicas como fator central dessa perda de independência.
- Pesquisadores alertam que hospitais e serviços de assistência social enfrentarão pressão crescente com o acompanhamento prolongado de sobreviventes que precisam de reabilitação renal, pulmonar e funcional.
- O estudo reforça a vacinação como estratégia essencial: prevenir a infecção grave é, segundo os autores, o caminho mais eficaz para evitar um ciclo de complicações cujas consequências se estendem muito além da alta hospitalar.
Pesquisadores britânicos analisaram dados de mais de 70 mil pacientes hospitalizados com COVID-19 em quase 300 hospitais do Reino Unido, entre janeiro e agosto de 2020 — antes das vacinas e das novas variantes. O resultado, publicado no Lancet em meados de julho de 2021, é o retrato mais abrangente já feito das complicações agudas da doença: metade dos internados desenvolveu ao menos uma complicação grave durante a hospitalização.
As complicações foram variadas e sérias: lesão renal aguda, síndrome do desconforto respiratório, dano hepático, anemia e arritmia cardíaca lideraram a lista, acompanhadas de complicações neurológicas, gastrointestinais e cardiovasculares. O dado que mais surpreende, porém, é a distribuição etária: 27% dos pacientes entre 19 e 29 anos e 37% dos pacientes entre 30 e 39 anos desenvolveram ao menos uma complicação — evidência de que a doença não poupa os mais jovens.
O custo humano foi pesado. Quase um terço dos participantes morreu. Entre os que receberam alta, 27% saíram do hospital menos capazes de cuidar de si mesmos do que antes da infecção. Mesmo entre os mais jovens, 13% dos sobreviventes de 19 a 29 anos e 17% dos de 30 a 39 anos perderam capacidade funcional. As complicações neurológicas mostraram ligação direta com essa perda de autonomia.
Calum Semple, da Universidade de Liverpool e coordenador do estudo, foi direto: os dados contradizem a narrativa de que a COVID-19 é perigosa apenas para idosos e pessoas com doenças preexistentes. Ewen Harrison, da Universidade de Edimburgo, alertou que muitos sobreviventes enfrentarão consequências de longo prazo. Thomas Drake, também de Edimburgo, defendeu que os formuladores de políticas precisam olhar além dos números de mortalidade — porque o verdadeiro peso da pandemia inclui meses de recuperação, função perdida e serviços de saúde sobrecarregados por uma demanda que não termina na alta hospitalar.
British researchers analyzing data from more than 70,000 hospitalized COVID-19 patients have documented a sobering reality: half of those admitted to hospitals developed at least one complication during their stay. The findings, published in the Lancet in mid-July 2021, represent the most comprehensive systematic examination to date of the range of complications that emerge in hospitalized COVID patients, their connection to age and demographic factors, and what happens to survivors after discharge.
The complications were diverse and serious. Kidney injury, respiratory distress, and systemic complications dominated the list, but the researchers also documented cardiovascular, neurological, gastrointestinal, and liver damage across the cohort. The data came from nearly 300 hospitals across the United Kingdom, collected between January and August 2020—before vaccination campaigns began and before new variants emerged. Nurses and medical students gathered patient information at multiple points during hospitalization and tracked outcomes through discharge or, if patients remained hospitalized, through day 28.
What stands out most sharply is that these complications were not confined to the elderly or the already-sick. Men and people over 60 did face higher risk, but the study found elevated complication rates across every age group examined. Among patients aged 19 to 29, more than a quarter—27 percent—developed at least one complication. For those in their thirties, the rate climbed to 37 percent. Young, previously healthy adults were not spared. The most frequently observed specific complications were acute kidney injury, acute respiratory distress syndrome, liver injury, anemia, and cardiac arrhythmia.
The human toll was substantial. Nearly one in three study participants—32 percent—died. Among those who survived and were discharged, a striking proportion lost functional capacity. Twenty-seven percent of survivors were less able to care for themselves after leaving the hospital than they had been before COVID-19. This decline in self-care ability was most pronounced among older patients, men, and those who had required intensive care. Even among the youngest survivors, aged 19 to 29, thirteen percent left the hospital unable to manage their own daily needs at the level they had before infection. For those in their thirties, the figure reached 17 percent. Neurological complications appeared particularly linked to this loss of independence.
Calum Semple, the study's lead investigator from the University of Liverpool, framed the findings as a direct challenge to prevailing narratives about who COVID-19 threatens. "The study contradicts current claims that COVID-19 is dangerous only for people with existing health problems and older adults," he said in a statement. The research, he emphasized, underscores that disease severity at hospital admission predicts complications even in younger adults, making vaccination—as a strategy to prevent severe infection in the first place—essential.
The complications documented here differ from the long COVID symptoms reported by people who were sick enough to need hospitalization but recovered at home. These are acute, hospital-acquired complications that emerged during acute illness. Yet their consequences extend far beyond the hospital stay. Ewen Harrison from the University of Edinburgh noted that those with complications "presented with worse health at discharge and some will face long-term consequences." The burden falls not only on individual patients but on health systems already strained by the pandemic. The researchers warn that substantial pressure will mount on hospitals and social care services as survivors require specialized follow-up care—kidney clinics for those with acute kidney injury, respiratory support for those with lung damage, and broader rehabilitation services for those struggling to regain independence.
Thomas Drake, also from Edinburgh, stressed that policymakers need to see beyond mortality figures. "It is important to consider not only death from COVID-19, but also other complications," he said. The data, he argued, should inform decisions about pandemic response and future planning. The implication is clear: the true cost of COVID-19 hospitalization extends well beyond the intensive care unit and into months of recovery, lost function, and strained social services.
Citações Notáveis
The study contradicts current claims that COVID-19 is dangerous only for people with existing health problems and older adults.— Calum Semple, lead investigator, University of Liverpool
It is important to consider not only death from COVID-19, but also other complications when planning pandemic response and future healthcare needs.— Thomas Drake, University of Edinburgh
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that complications appeared in young, healthy people? Isn't that what we'd expect from any serious illness?
The difference is in the narrative. Before this study, many people believed COVID was essentially a disease of the elderly and the already-sick. Young healthy people thought they had little to fear. This data says otherwise—more than a quarter of people in their twenties developed complications. That changes the risk calculus for individuals and for public health messaging.
But 27 percent is still a minority. Doesn't that mean most young people hospitalized didn't develop complications?
True, but you have to remember: these are people sick enough to be hospitalized. The study isn't saying a quarter of all young people who get COVID develop complications. It's saying a quarter of young people sick enough to need hospital care do. That's a very different group. And even among those without complications, a third of all participants died.
The self-care numbers are striking—27 percent of survivors couldn't care for themselves after discharge. How long does that last?
The study doesn't specify. It measured capacity at discharge. Some may recover function quickly; others may not. That's precisely why the researchers are calling for follow-up clinics and rehabilitation services. The uncertainty itself is part of the burden on the health system.
Why does the study emphasize vaccination so heavily if it was conducted before vaccines existed?
Because the researchers are saying: this is what happens when people get sick enough to be hospitalized. Vaccination prevents that severity in the first place. It's not about treating complications after the fact—it's about preventing the hospitalization that leads to complications. That's the primary prevention strategy.
What about the racial disparities mentioned—higher complication rates among Black patients?
The study notes it but doesn't deeply analyze why. It's a documented pattern but the mechanism isn't explored here. That's a question for follow-up research, and it points to broader inequities in who gets severely ill and why.